Resolution Therapeutics Announces £63.5 Million Series B …

Oct 3, 2024 · Edinburgh and London, UK, 3 October 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on unlocking the …

CouponFollow Extension

£63
OFF

Resolution Therapeutics Announces £63.5 Million Series B …

2 days from now

Oct 3, 2024 · Edinburgh and London, UK, 3 October 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company focused on unlocking the …

resolution-tx.com

£63
OFF

Resolution Therapeutics Announces £63.5 Million Series B …

2 days from now

Oct 3, 2024 · EDINBURGH, Scotland and LONDON, Oct. 3, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on …

prnewswire.com

£63
OFF

Edinburgh Innovations | Spinout Resolution Therapeutics …

2 days from now

Jun 5, 2024 · Biotech spinout Resolution Therapeutics has announced it has raised £63.5 million in a series B financing round led by healthcare investor Syncona Ltd. The company, founded …

ed.ac.uk

£63
OFF

Edinburgh HQ'd Resolution Therapeutics Announced A £63.5M …

2 days from now

Oct 9, 2024 · Edinburgh HQ'd Resolution Therapeutics announced a £63.5M series B this month to advance its pro-regenerative macrophage therapy into further end-stage liver disease …

biotechtv.com

£63
OFF

Edinburgh’s Resolution Therapeutics Raises £63m

2 days from now

Oct 3, 2024 · Edinburgh-based Resolution Therapeutics Limited announced it has raised £63.5 million in Series B financing round led by investment firm Syncona Ltd. Resolution is a clinical …

scottishfinancialreview.com

£63
OFF

Resolution Therapeutics Raises £63.5M In Series B Financing

2 days from now

Oct 3, 2024 · Resolution Therapeutics, an Edinburgh, Scotland, and London, UK-based clinical-stage biopharmaceutical company, raised £63.5M in Series B funding.. The round was led by …

finsmes.com

£63
OFF

Resolution Therapeutics Announces £63.5 Million Series B …

2 days from now

Oct 3, 2024 · EDINBURGH, Scotland and LONDON, Oct. 3, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on …

epicos.com

£63500000
OFF

Resolution Therapeutics Closed £63,500,000 In A Remarkable …

2 days from now

Oct 3, 2024 · Resolution Therapeutics, a forward-thinking and innovative biopharmaceutical company based in the vibrant cities of Edinburgh, Scotland, and London, UK, has successfully …

startupmag.co.uk

£26
OFF

Resolution Therapeutics Announces A £26.6m Series A ... - Syncona

2 days from now

May 6, 2024 · Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases characterised by life-threatening …

synconaltd.com

£10
OFF

Resolution Therapeutics Announces £10m Boost… - Edinburgh …

2 days from now

The £10 million investment extends Series A financing of £26.6 million from Syncona, a specialist healthcare investment company, that was announced at the launch of Resolution in December …

ed.ac.uk

£63
OFF

Resolution Therapeutics Announces £63.5 Million Series B …

2 days from now

Oct 3, 2024 · EDINBURGH, Scotland and LONDON, Oct. 3, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on …

ceo.ca

£26
OFF

Resolution Therapeutics Announces A £26.6m Series A Financing …

2 days from now

London, 2 December 2020 – Resolution Therapeutics Limited (“Resolution”), a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases characterised by life …

resolution-tx.com

$83
OFF

Resolution Therapeutics Secures $83M To Advance Liver Therapy

2 days from now

Oct 3, 2024 · Resolution Therapeutics was co-founded by Syncona, a UK-based investment trust focused on helping to found, fund and progress healthcare companies, in 2020 after a two …

biopharma-reporter.com

FAQs about Resolution Therapeutics Announces £63.5 Million Series B … Coupon?

What's new at resolution Therapeutics?

Edinburgh Innovations | Resolution Therapeutics announces £10m boost… Resolution Therapeutics, a biopharmaceutical spinout company developing macrophage cell therapy to treat advanced liver disease, has completed a £10 million financing extension from Syncona and announced a new collaboration with biotech firm panCELLa. ...

Is resolution a regenerative biopharmaceutical company?

EDINBURGH, Scotland and LONDON, Oct. 3, 2024 /PRNewswire/ -- Resolution Therapeutics Limited ("Resolution"), a clinical-stage biopharmaceutical company focused on unlocking the regenerative potential of macrophage therapy for the treatment of inflammatory and fibrotic diseases, today announces it has raised £63.5 million in Series B financing. ...

Who founded resolution Therapeutics?

In 2020, Professor Forbes co-founded Resolution Therapeutics, a biotech company focused on engineering macrophage cell therapies to deliver a more effective and durable treatment for patients with end-stage liver disease. ...

What does the extended series A funding mean for resolution?

The extended Series A funding will allow Resolution to continue to develop its autologous macrophage cell therapies alongside broadening its research activity into the development of an allogeneic platform to produce “off-the-shelf” macrophage cell therapies. ...

What can resolution do for esld patients?

Resolution has also developed a platform to engineer and cryopreserve autologous macrophages with a pro-regenerative phenotype for the treatment of patients with ESLD. The data showcase an improved differentiation protocol and a more automated process to maximise manufacturing yields without compromising the phenotype. ...

What is Edinburgh innovations?

Edinburgh Innovations is the University of Edinburgh’s commercialisation service. We bring University of Edinburgh research to industry, working to identify ideas with value, and facilitating the process of bringing them to life in real-world applications. We make ideas work for a better world. ...